0001127602-12-026238.txt : 20120912 0001127602-12-026238.hdr.sgml : 20120912 20120912172412 ACCESSION NUMBER: 0001127602-12-026238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120911 FILED AS OF DATE: 20120912 DATE AS OF CHANGE: 20120912 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SHARER KEVIN W CENTRAL INDEX KEY: 0001185618 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 121088608 MAIL ADDRESS: STREET 1: AMGEN INC. STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-09-11 0000318154 AMGEN INC AMGN 0001185618 SHARER KEVIN W ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 1 Common Stock 2012-09-11 4 M 0 1598 62.55 A 102616 D Common Stock 2012-09-11 4 M 0 193402 62.55 A 296018 D Common Stock 2012-09-11 4 M 0 79625 58.43 A 375643 D Common Stock 2012-09-11 5 G 0 E 274625 0 A 423119 I Living Trust Common Stock 2012-09-11 5 G 0 E 274625 0 D 101018 D Common Stock 2012-09-11 4 S 0 274625 83.9618 D 148494 I Living Trust Common Stock 2012-09-11 4 S 0 50585 83.9639 D 97909 I Living Trust Common Stock 2012-09-11 4 S 0 24415 83.9665 D 73494 I Living Trust Common Stock 4433.6295 I By 401(k) Plan Iso (Right to Buy) 62.55 2012-09-11 4 M 0 1598 0 D 2011-04-26 2014-04-26 Common Stock 1598 0 D Nqso (Right to Buy) 62.55 2012-09-11 4 M 0 193402 0 D 2008-04-26 2014-04-26 Common Stock 193402 0 D Nqso (Right to Buy) 58.43 2012-09-11 4 M 0 79625 0 D 2011-04-26 2020-04-26 Common Stock 79625 159250 D These shares are being transferred to the reporting person's Living Trust. These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 9,250 RSUs which fully vest on 4/28/2013; 22,750 RSUs which vest in two equal annual installments of 11,375 each commencing 4/26/2013; 60,000 RSUs which vest in two equal installments of 19,800 each on 4/25/2013 and 4/25/2014 and one installment of 20,400 on 4/25/2015; and 8,933 RSUs which vest in three installments of 2,947, 2,948 and 3,038 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs are paid in shares of the Company's common stock on a one-to-one basis. These shares include 85 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. The price reported is an average price. The prices ranged from $83.79 to $84.12 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. The price reported is an average price. The prices ranged from $83.795 to $84.16 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer. These are shares acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing. /s/ Andrea Robinson, Attorney-in-Fact for Mr. Sharer 2012-09-12